Alexza Pharmaceuticals Inc. — Form D

Alexza Pharmaceuticals Inc. of MOUNTAIN VIEW, CA, a company, filed a Form D exempt-offering notice with the SEC on 2016-02-24. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2016-02-24
• Form: D
• Accession: 0001603018-16-000002
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $5.0M
• Amount sold: $5.0M
• Investors: 1
• Date of first sale: 2016-02-23
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-258073

Issuer

• Name: Alexza Pharmaceuticals Inc.
• CIK: 0001344413
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 2091 STIERLIN COURT, MOUNTAIN VIEW, CA, 94043
• Phone: 650.944.7000

Officers, directors & promoters (22)

Other filings by this issuer (8)

More

• CIK 1344413 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search